Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients. Becquemont, L., Bauduceau, B., Benattar-Zibi, L., Berrut, G., Bertin, P., Bucher, S., Corruble, E., Danchin, N., al-Salameh , A., Derumeaux, G., Doucet, J., Falissard, B., Forette, F., Hanon, O., Pasquier, F., Pinget, M., Ourabah, R., & Piedvache, C. Basic & Clinical Pharmacology & Toxicology, 117(2):137–143, August, 2015. doi abstract bibtex Concern about the renal safety of commonly used cardiovascular drugs with demonstrated clinical benefit appears to be an obstacle to their use in the elderly. The objective was to describe the relationship between cardiovascular drugs and chronic kidney disease (CKD) in elderly individuals in the real-life setting. This is an ancillary study of the prospective non-interventional S.AGE (aged individuals) cohort. General physicians were free to prescribe any drug their patients needed. The participants were non-institutionalized patients aged 65 years and older treated by their primary physician for either chronic pain or atrial fibrillation or type 2 diabetes mellitus. The estimated glomerular filtration rate (eGFR) derived from the CKD-EPI formula was determined at inclusion and every year during 2 years of follow-up. This study comprised 2505 patients aged 77.8 ± 6.2 years. At inclusion, the factors associated with CKD (eGFR \textless 60 ml/min/1.73 m(2) ) in multivariate analysis were age, female gender, hypertension, heart failure, history of atherothrombotic disease and renin angiotensin system blockers, loop diuretics and calcium channel inhibitors. Introduction of each of these three drug classes during the follow-up period led to only a small decrease in the eGFR: -3.8 ± 12.7 (p \textless 0.0006), -2.2 ± 12.0 (p \textless 0.003) and -1.0 ± 13.4 ml/min./1.73 m(2) (NS), respectively. Only the introduction of loop diuretics was associated with CKD (OR 1.91, 95% CI: 1.25-2.90; p = 0.002). Renal safety of cardiovascular drugs in the elderly appears acceptable and should not be a barrier to their use.
@article{becquemont_association_2015,
title = {Association between {Cardiovascular} {Drugs} and {Chronic} {Kidney} {Disease} in {Non}-{Institutionalized} {Elderly} {Patients}},
volume = {117},
issn = {1742-7843},
doi = {10.1111/bcpt.12376},
abstract = {Concern about the renal safety of commonly used cardiovascular drugs with demonstrated clinical benefit appears to be an obstacle to their use in the elderly. The objective was to describe the relationship between cardiovascular drugs and chronic kidney disease (CKD) in elderly individuals in the real-life setting. This is an ancillary study of the prospective non-interventional S.AGE (aged individuals) cohort. General physicians were free to prescribe any drug their patients needed. The participants were non-institutionalized patients aged 65 years and older treated by their primary physician for either chronic pain or atrial fibrillation or type 2 diabetes mellitus. The estimated glomerular filtration rate (eGFR) derived from the CKD-EPI formula was determined at inclusion and every year during 2 years of follow-up. This study comprised 2505 patients aged 77.8 ± 6.2 years. At inclusion, the factors associated with CKD (eGFR {\textless} 60 ml/min/1.73 m(2) ) in multivariate analysis were age, female gender, hypertension, heart failure, history of atherothrombotic disease and renin angiotensin system blockers, loop diuretics and calcium channel inhibitors. Introduction of each of these three drug classes during the follow-up period led to only a small decrease in the eGFR: -3.8 ± 12.7 (p {\textless} 0.0006), -2.2 ± 12.0 (p {\textless} 0.003) and -1.0 ± 13.4 ml/min./1.73 m(2) (NS), respectively. Only the introduction of loop diuretics was associated with CKD (OR 1.91, 95\% CI: 1.25-2.90; p = 0.002). Renal safety of cardiovascular drugs in the elderly appears acceptable and should not be a barrier to their use.},
language = {eng},
number = {2},
journal = {Basic \& Clinical Pharmacology \& Toxicology},
author = {Becquemont, Laurent and Bauduceau, Bernard and Benattar-Zibi, Linda and Berrut, Gilles and Bertin, Philippe and Bucher, Sophie and Corruble, Emmanuelle and Danchin, Nicolas and al-Salameh, Abdallah and Derumeaux, Geneviève and Doucet, Jean and Falissard, Bruno and Forette, Francoise and Hanon, Olivier and Pasquier, Florence and Pinget, Michel and Ourabah, Rissane and Piedvache, Celine},
month = aug,
year = {2015},
pmid = {25594245},
keywords = {Aged, Humans, Female, Male, Prospective Studies, Aged, 80 and over, Follow-Up Studies, Risk Factors, Age Factors, Sex Factors, Multivariate Analysis, Atrial Fibrillation, Chronic Pain, Diabetes Mellitus, Type 2, Cardiovascular Agents, Glomerular Filtration Rate, Renal Insufficiency, Chronic, Sodium Potassium Chloride Symporter Inhibitors},
pages = {137--143}
}
Downloads: 0
{"_id":"d6ELw6vF5K3xxF7DM","bibbaseid":"becquemont-bauduceau-benattarzibi-berrut-bertin-bucher-corruble-danchin-etal-associationbetweencardiovasculardrugsandchronickidneydiseaseinnoninstitutionalizedelderlypatients-2015","authorIDs":[],"author_short":["Becquemont, L.","Bauduceau, B.","Benattar-Zibi, L.","Berrut, G.","Bertin, P.","Bucher, S.","Corruble, E.","Danchin, N.","al-Salameh , A.","Derumeaux, G.","Doucet, J.","Falissard, B.","Forette, F.","Hanon, O.","Pasquier, F.","Pinget, M.","Ourabah, R.","Piedvache, C."],"bibdata":{"bibtype":"article","type":"article","title":"Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients","volume":"117","issn":"1742-7843","doi":"10.1111/bcpt.12376","abstract":"Concern about the renal safety of commonly used cardiovascular drugs with demonstrated clinical benefit appears to be an obstacle to their use in the elderly. The objective was to describe the relationship between cardiovascular drugs and chronic kidney disease (CKD) in elderly individuals in the real-life setting. This is an ancillary study of the prospective non-interventional S.AGE (aged individuals) cohort. General physicians were free to prescribe any drug their patients needed. The participants were non-institutionalized patients aged 65 years and older treated by their primary physician for either chronic pain or atrial fibrillation or type 2 diabetes mellitus. The estimated glomerular filtration rate (eGFR) derived from the CKD-EPI formula was determined at inclusion and every year during 2 years of follow-up. This study comprised 2505 patients aged 77.8 ± 6.2 years. At inclusion, the factors associated with CKD (eGFR \\textless 60 ml/min/1.73 m(2) ) in multivariate analysis were age, female gender, hypertension, heart failure, history of atherothrombotic disease and renin angiotensin system blockers, loop diuretics and calcium channel inhibitors. Introduction of each of these three drug classes during the follow-up period led to only a small decrease in the eGFR: -3.8 ± 12.7 (p \\textless 0.0006), -2.2 ± 12.0 (p \\textless 0.003) and -1.0 ± 13.4 ml/min./1.73 m(2) (NS), respectively. Only the introduction of loop diuretics was associated with CKD (OR 1.91, 95% CI: 1.25-2.90; p = 0.002). Renal safety of cardiovascular drugs in the elderly appears acceptable and should not be a barrier to their use.","language":"eng","number":"2","journal":"Basic & Clinical Pharmacology & Toxicology","author":[{"propositions":[],"lastnames":["Becquemont"],"firstnames":["Laurent"],"suffixes":[]},{"propositions":[],"lastnames":["Bauduceau"],"firstnames":["Bernard"],"suffixes":[]},{"propositions":[],"lastnames":["Benattar-Zibi"],"firstnames":["Linda"],"suffixes":[]},{"propositions":[],"lastnames":["Berrut"],"firstnames":["Gilles"],"suffixes":[]},{"propositions":[],"lastnames":["Bertin"],"firstnames":["Philippe"],"suffixes":[]},{"propositions":[],"lastnames":["Bucher"],"firstnames":["Sophie"],"suffixes":[]},{"propositions":[],"lastnames":["Corruble"],"firstnames":["Emmanuelle"],"suffixes":[]},{"propositions":[],"lastnames":["Danchin"],"firstnames":["Nicolas"],"suffixes":[]},{"propositions":["al-Salameh"],"lastnames":[],"firstnames":["Abdallah"],"suffixes":[]},{"propositions":[],"lastnames":["Derumeaux"],"firstnames":["Geneviève"],"suffixes":[]},{"propositions":[],"lastnames":["Doucet"],"firstnames":["Jean"],"suffixes":[]},{"propositions":[],"lastnames":["Falissard"],"firstnames":["Bruno"],"suffixes":[]},{"propositions":[],"lastnames":["Forette"],"firstnames":["Francoise"],"suffixes":[]},{"propositions":[],"lastnames":["Hanon"],"firstnames":["Olivier"],"suffixes":[]},{"propositions":[],"lastnames":["Pasquier"],"firstnames":["Florence"],"suffixes":[]},{"propositions":[],"lastnames":["Pinget"],"firstnames":["Michel"],"suffixes":[]},{"propositions":[],"lastnames":["Ourabah"],"firstnames":["Rissane"],"suffixes":[]},{"propositions":[],"lastnames":["Piedvache"],"firstnames":["Celine"],"suffixes":[]}],"month":"August","year":"2015","pmid":"25594245","keywords":"Aged, Humans, Female, Male, Prospective Studies, Aged, 80 and over, Follow-Up Studies, Risk Factors, Age Factors, Sex Factors, Multivariate Analysis, Atrial Fibrillation, Chronic Pain, Diabetes Mellitus, Type 2, Cardiovascular Agents, Glomerular Filtration Rate, Renal Insufficiency, Chronic, Sodium Potassium Chloride Symporter Inhibitors","pages":"137–143","bibtex":"@article{becquemont_association_2015,\n\ttitle = {Association between {Cardiovascular} {Drugs} and {Chronic} {Kidney} {Disease} in {Non}-{Institutionalized} {Elderly} {Patients}},\n\tvolume = {117},\n\tissn = {1742-7843},\n\tdoi = {10.1111/bcpt.12376},\n\tabstract = {Concern about the renal safety of commonly used cardiovascular drugs with demonstrated clinical benefit appears to be an obstacle to their use in the elderly. The objective was to describe the relationship between cardiovascular drugs and chronic kidney disease (CKD) in elderly individuals in the real-life setting. This is an ancillary study of the prospective non-interventional S.AGE (aged individuals) cohort. General physicians were free to prescribe any drug their patients needed. The participants were non-institutionalized patients aged 65 years and older treated by their primary physician for either chronic pain or atrial fibrillation or type 2 diabetes mellitus. The estimated glomerular filtration rate (eGFR) derived from the CKD-EPI formula was determined at inclusion and every year during 2 years of follow-up. This study comprised 2505 patients aged 77.8 ± 6.2 years. At inclusion, the factors associated with CKD (eGFR {\\textless} 60 ml/min/1.73 m(2) ) in multivariate analysis were age, female gender, hypertension, heart failure, history of atherothrombotic disease and renin angiotensin system blockers, loop diuretics and calcium channel inhibitors. Introduction of each of these three drug classes during the follow-up period led to only a small decrease in the eGFR: -3.8 ± 12.7 (p {\\textless} 0.0006), -2.2 ± 12.0 (p {\\textless} 0.003) and -1.0 ± 13.4 ml/min./1.73 m(2) (NS), respectively. Only the introduction of loop diuretics was associated with CKD (OR 1.91, 95\\% CI: 1.25-2.90; p = 0.002). Renal safety of cardiovascular drugs in the elderly appears acceptable and should not be a barrier to their use.},\n\tlanguage = {eng},\n\tnumber = {2},\n\tjournal = {Basic \\& Clinical Pharmacology \\& Toxicology},\n\tauthor = {Becquemont, Laurent and Bauduceau, Bernard and Benattar-Zibi, Linda and Berrut, Gilles and Bertin, Philippe and Bucher, Sophie and Corruble, Emmanuelle and Danchin, Nicolas and al-Salameh, Abdallah and Derumeaux, Geneviève and Doucet, Jean and Falissard, Bruno and Forette, Francoise and Hanon, Olivier and Pasquier, Florence and Pinget, Michel and Ourabah, Rissane and Piedvache, Celine},\n\tmonth = aug,\n\tyear = {2015},\n\tpmid = {25594245},\n\tkeywords = {Aged, Humans, Female, Male, Prospective Studies, Aged, 80 and over, Follow-Up Studies, Risk Factors, Age Factors, Sex Factors, Multivariate Analysis, Atrial Fibrillation, Chronic Pain, Diabetes Mellitus, Type 2, Cardiovascular Agents, Glomerular Filtration Rate, Renal Insufficiency, Chronic, Sodium Potassium Chloride Symporter Inhibitors},\n\tpages = {137--143}\n}\n\n","author_short":["Becquemont, L.","Bauduceau, B.","Benattar-Zibi, L.","Berrut, G.","Bertin, P.","Bucher, S.","Corruble, E.","Danchin, N.","al-Salameh , A.","Derumeaux, G.","Doucet, J.","Falissard, B.","Forette, F.","Hanon, O.","Pasquier, F.","Pinget, M.","Ourabah, R.","Piedvache, C."],"key":"becquemont_association_2015","id":"becquemont_association_2015","bibbaseid":"becquemont-bauduceau-benattarzibi-berrut-bertin-bucher-corruble-danchin-etal-associationbetweencardiovasculardrugsandchronickidneydiseaseinnoninstitutionalizedelderlypatients-2015","role":"author","urls":{},"keyword":["Aged","Humans","Female","Male","Prospective Studies","Aged","80 and over","Follow-Up Studies","Risk Factors","Age Factors","Sex Factors","Multivariate Analysis","Atrial Fibrillation","Chronic Pain","Diabetes Mellitus","Type 2","Cardiovascular Agents","Glomerular Filtration Rate","Renal Insufficiency","Chronic","Sodium Potassium Chloride Symporter Inhibitors"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://github.com/leromela/bibtex/blob/main/Centre_Memoire.bib?raw=true","creationDate":"2021-03-09T16:04:10.227Z","downloads":0,"keywords":["aged","humans","female","male","prospective studies","aged","80 and over","follow-up studies","risk factors","age factors","sex factors","multivariate analysis","atrial fibrillation","chronic pain","diabetes mellitus","type 2","cardiovascular agents","glomerular filtration rate","renal insufficiency","chronic","sodium potassium chloride symporter inhibitors"],"search_terms":["association","between","cardiovascular","drugs","chronic","kidney","disease","non","institutionalized","elderly","patients","becquemont","bauduceau","benattar-zibi","berrut","bertin","bucher","corruble","danchin","al-salameh ","derumeaux","doucet","falissard","forette","hanon","pasquier","pinget","ourabah","piedvache"],"title":"Association between Cardiovascular Drugs and Chronic Kidney Disease in Non-Institutionalized Elderly Patients","year":2015,"dataSources":["j489FYr48Mag45aCq"]}